Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genes

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Stjepanovic D ^a   Lorenzetti, V ^b,c   Yucel M ^b,c   Hawi, Z ^a,c   Bellgrove, M A ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

amygdala; genetics; morphology; oxytocin; serotonin; stathmin

Indexed keywords

DNA; SEROTONIN TRANSPORTER; STATHMIN; SLC6A4 PROTEIN, HUMAN; STMN1 PROTEIN, HUMAN;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; DNA POLYMORPHISM; FEMALE; GENOTYPING TECHNIQUE; HUMAN; MALE; MEASUREMENT; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; ADOLESCENT; ANATOMY AND HISTOLOGY; CAUCASIAN; GENETIC VARIABILITY; GENETICS; GENOTYPE; ORGAN SIZE; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; HISTOLOGY;

ADOLESCENT; ADULT; AMYGDALA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATHMIN; YOUNG ADULT;

EID: 84880517865     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.41     Document Type: Article

References (83)

1. Dolan RJ. Emotion, cognition, and behavior. Science 2002; 298: 1191-1194.
2. Whittle S, Allen NB, Lubman DI, Yü cel M. The neurobiological basis of temperament: towards a better understanding of psychopathology. Neurosci Biobehav Rev 2006; 30: 511-525.
3. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR. A mechanism for impaired fear recognition after amygdala damage. Nature 2005; 433: 68-72. (Pubitemid 40101144)
4. Killcross S, Robbins TW, Everitt BJ. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 1997; 388: 377-380. (Pubitemid 27334815)
5. McDonald RJ, White NM. A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav Neurosci 1993; 107: 3-22. (Pubitemid 23187254)
6. Adolphs R, Tranel D, Denburg N. Impaired emotional declarative memory following unilateral amygdala damage. Learn Mem 2000; 7: 180-186. (Pubitemid 30407783)
7. Young AW, Aggleton JP, Hellawell DJ, Johnson M, Broks P, Hanley JR. Face processing impairments after amygdalotomy. Brain 1995; 118: 15-24.
8. Broks P, Young AW, Maratos EJ, Coffey PJ, Calder AJ, Isaac CL et al. Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia 1998; 36: 59-70. (Pubitemid 28105197)
9. Lipka J, Miltner WHR, Straube T. Vigilance for threat interacts with amygdala responses to subliminal threat cues in specific phobia. Biol Psychiat 2011; 70: 472-478.
10. Stein MB, Goldin PR, Sareen J, Zorrilla LTE, Brown GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiat 2002; 59: 1027-1034.
11. Canli T, Sivers H, Thomason ME, Whitfield-Gabrieli S, Gabrieli JDE, Gotlib IH. Brain activation to emotional words in depressed vs healthy subjects. Neuroreport 2004; 15: 2585-2588. (Pubitemid 40053942)
12. Canli T, Cooney RE, Goldin P, Shah M, Sivers H, Thomason ME et al. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 2005; 16: 1267-1270. (Pubitemid 41225193)
13. Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in major depressive disorder: a metaanalysis of magnetic resonance imaging studies. Mol Psychiatry 2008; 13: 993-1000.
14. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiat 1999; 56: 913-919. (Pubitemid 29480127)
15. Dalton KM, Nacewicz BM, Alexander AL, Davidson RJ. Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism. Biol Psychiat 2007; 61: 512-520. (Pubitemid 46185335)
16. Hulshoff Pol HE, Schnack HG, Posthuma D, Mandl RCW, Baaré WFC, van Oel C et al. Genetic contributions to human brain morphology and intelligence. J Neurosci 2006; 26: 10235-10242. (Pubitemid 44527417)
17. Kremen WS, Prom-Wormley E, Panizzon MS, Eyler LT, Fischl B, Neale MC et al. Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. NeuroImage 2010; 49: 1213-1223.
18. Wendland JR, Martin BJ, Kruse MR, Lesch K-PP, Murphy DL. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 2006; 11: 224-226.
19. Kraft JB, Slager SL, McGrath PJ, Hamilton SP. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiat 2005; 58: 374-381. (Pubitemid 41219705)
20. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-2624. (Pubitemid 26159101)
21. Rao H, Gillihan SJ, Wang J, Korczykowski M, Sankoorikal GMV, Kaercher KA et al. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiat 2007; 62: 600-606. (Pubitemid 47314381)
22. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400-403. (Pubitemid 34790769)
23. Serretti A, Kato M, de Ronchi D, Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007; 12: 247-257. (Pubitemid 46328503)
24. Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiat 2008; 63: 852-857. (Pubitemid 351458448)
25. Scherk H, Gruber O, Menzel P, Schneider-Axmann T, Kemmer C, Usher J et al. 5-HTTLPR genotype influences amygdala volume. Eur Arch Psychiatry Clin Neurosci 2009; 259: 212-217.
26. Hu X-Z, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006; 78: 815-826.
27. Hu X-Z, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8-16. (Pubitemid 40129206)
28. Martin J, Cleak J, Willis-Owen SAG, Flint J, Shifman S. Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol Psychiatry 2007; 12: 421-422. (Pubitemid 46652459)
29. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang Y-Y et al. Effect of a triallelic functional polymorphism of the serotonin-transporter- linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006; 163: 48-51. (Pubitemid 43050102)
30. Jasinska AJ, Chua HF, Ho SS, Polk TA, Rozek LS, Strecher VJ. Amygdala response to smoking-cessation messages mediates the effects of serotonin transporter gene variation on quitting. NeuroImage 2012; 60: 766-773.
31. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999; 88: 61-66. (Pubitemid 29075323)
32. Kohen R, Cain KC, Mitchell PH, Becker K, Buzaitis A, Millard SP et al. Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiat 2008; 65: 1296-1302.
33. MacKenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251-15255. (Pubitemid 30019798)
34. Fiskerstrand CE, Lovejoy EA, Quinn JP. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 1999; 458: 171-174. (Pubitemid 29428177)
35. Lovejoy EA, Scott AC, Fiskerstrand CE, Bubb VJ, Quinn JP. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur J Neurosci 2003; 17: 417-420. (Pubitemid 36459521)
36. Bah J, Lindström M, Westberg L, Mannera°s L, Ryding E, Henningsson S et al. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res 2008; 162: 221-229.
37. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K, Ohara K. A variable-number-tandemrepeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 55-65. (Pubitemid 29098902)
38. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996; 7: 1675-1679. (Pubitemid 26332347)
39. Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 2004; 55: 1090-1094. (Pubitemid 38680561)
40. Ali FR, Vasiliou SA, Haddley K, Paredes UM, Roberts JC, Miyajima F et al. Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF. J Neurochem 2010; 112: 296-306.
41. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12: 524-538.
42. Veinante P, Freund-Mercier MJ. Distribution of oxytocin-and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J Comp Neurol 1997; 383: 305-325. (Pubitemid 27280078)
43. Tost H, Kolachana B, Hakimi S, Lemaitre H, Verchinski BA, Mattay VS et al. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc Natl Acad Sci USA 2010; 107: 13936-13941.
44. Peschanski M, Hirsch E, Dusart I, Doye V, Marty S, Manceau V et al. Stathmin: cellular localization of a major phosphoprotein in the adult rat and human CNS. J Comp Neurol 1993; 337: 655-668. (Pubitemid 23323650)
45. Martel G, Nishi A, Shumyatsky GP. Stathmin reveals dissociable roles of the basolateral amygdala in parental and social behaviors. Proc Natl Acad Sci USA 2008; 105: 14620-14625.
46. Shumyatsky GP, Malleret G, Shin R-M, Takizawa S, Tully K, Tsvetkov E et al. Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell 2005; 123: 697-709. (Pubitemid 41608470)
47. Brocke B, Lesch K-PP, Armbruster D, Moser DA, Mü ller A, Strobel A et al. Stathmin, a gene regulating neural plasticity, affects fear and anxiety processing in humans. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 243-251.
48. Morey RA, Petty CM, Xu Y, Hayes JP, Wagner HR, Lewis DV et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. NeuroImage 2009; 45: 855-866.
49. Ehlis A-C, Bauernschmitt K, Dresler T, Hahn T, Herrmann MJ, Rö ser C et al. Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: an event-related potential study. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 291-302.
50. Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW, Smith SM. FSL. NeuroImage 2012; 62: 782-790.
51. Smith SM. Fast robust automated brain extraction. Human Brain Mapping 2002; 17: 143-155. (Pubitemid 35253488)
52. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002; 17: 825-841. (Pubitemid 35317016)
53. Velakoulis D, Wood SJ, Wong MTH, McGorry PD, Yung A, Phillips L et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiat 2006; 63: 139-149. (Pubitemid 43213875)
54. Watson C, Andermann F, Gloor P, Jones-Gotman M, Peters T, Evans A et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992; 42: 1743-1750.
55. Lorenzetti V, Allen NB, Whittle S, Yü cel M. Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls. J Affect Disord 2010; 120: 112-119.
56. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
57. Sarosi A, Gonda X, Balogh G, Domotor E, Szekely A, Hejjas K et al. Association of the STin2 polymorphism of the serotonin transporter gene with a neurocognitive endophenotype in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1667-1672.
58. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA 2009; 106: 21437-21441.
59. Bakermans-Kranenburg MJ, van Ijzendoorn MH. Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc Cogn Affect Neurosci 2008; 3: 128-134. (Pubitemid 351827056)
60. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol 1980; 37: 625-629. (Pubitemid 10018487)
61. Bogerts B, Meertz E, Schönfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiat 1985; 42: 784-791. (Pubitemid 15244829)
62. Heckers S, Heinsen H, Heinsen YC, Beckmann H. Limbic structures and lateral ventricle in schizophrenia: a quantitative postmortem study. Arch Gen Psychiat 1990; 47: 1016-1022. (Pubitemid 20377511)
63. Scott SA, DeKosky ST, Scheff SW. Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology 1991; 41: 351-356.
64. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310. (Pubitemid 16134762)
65. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160. (Pubitemid 29425900)
66. Nugent AC, Luckenbaugh DA, Wood SE, Bogers W, Zarate CA, Drevets WC. Automated subcortical segmentation using FIRST: Test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum Brain Map 2013 (in press).
67. Pedraza O, Bowers D, Gilmore R. Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults. J Int Neuropsychol Soc 2004; 10: 664-678. (Pubitemid 39264092)
68. Chance SA, Esiri MM, Crow TJ. Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry 2002; 180: 331-338. (Pubitemid 34407320)
69. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834. (Pubitemid 43085851)
70. Brierley B, Shaw P, David AS. The human amygdala: a systematic review and metaanalysis of volumetric magnetic resonance imaging. Brain Res Brain Res Rev 2002; 39: 84-105. (Pubitemid 34666988)
71. Field A. Discovering Statistics Using SPSS. 3rd edn SAGE Publications Limited: London, UK, 2009.
72. Jourdain L, Curmi P, Sobel A, Pantaloni D, Carlier M-F. Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry 1997; 36: 10817-10821. (Pubitemid 27396235)
73. Rubin CI, Atweh GF. The role of stathmin in the regulation of the cell cycle. J Cell Biochem 2004; 93: 242-250. (Pubitemid 44264202)
74. Baca-Garcia E, Vaquero-Lorenzo C, Diaz-Hernandez M, Rodriguez-Salgado B, Dolengevich-Segal H, Arrojo-Romero M et al. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 416-420. (Pubitemid 46210229)
75. Fan JB, Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 2005; 10: 928-38-891.
76. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996; 1: 453-460. (Pubitemid 126439785)
77. Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ et al. Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry 2012; 17: 49-61.
78. Cerasa A, Quattrone A, Gioia MC, Magariello A, Muglia M, Assogna F et al. MAO A VNTR polymorphism and amygdala volume in healthy subjects. Psychiatry Res 2011; 191: 87-91.
79. Domschke K, Baune BT, Havlik L, Stuhrmann A, Suslow T, Kugel H et al. Catechol-Omethyltransferase gene variation: Impact on amygdala response to aversive stimuli. NeuroImage 2012; 60: 2222-2229.
80. Fakra E, Hyde LW, Gorka A, Fisher PM, Munoz KE, Kimak M et al. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiat 2009; 66: 33-40.
81. Booij L, Turecki G, Leyton M, Gravel P, Lopez De Lara C, Diksic M et al. Tryptophan hydroxylase2 gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol Psychiatry 2012; 17: 809-817.
82. Lohoff FW, Hodge R, Narasimhan S, Nall A, Ferraro TN, Mickey BJ et al. Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry 2013 (in press).
83. Outhred T, Das P, Dobson-Stone C, Griffiths K, Felmingham KL, Bryant RA et al. The functional epistasis of 5-HTTLPR and BDNF Val66Met on emotion processing: a preliminary study. Brain Behav 2012; 2: 778-788.